These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 30710427)
1. Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis. Rai R; Sun T; Ramirez V; Lux E; Eren M; Vaughan DE; Ghosh AK J Cell Mol Med; 2019 Apr; 23(4):3026-3031. PubMed ID: 30710427 [TBL] [Abstract][Full Text] [Related]
2. A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis. Rai R; Verma SK; Kim D; Ramirez V; Lux E; Li C; Sahoo S; Wilsbacher LD; Vaughan DE; Quaggin SE; Ghosh AK Epigenetics; 2017; 12(11):1004-1013. PubMed ID: 28933600 [TBL] [Abstract][Full Text] [Related]
3. Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice. Su H; Zeng H; He X; Zhu SH; Chen JX J Am Heart Assoc; 2020 Sep; 9(18):e017176. PubMed ID: 32865093 [TBL] [Abstract][Full Text] [Related]
4. Curcumin prevents and reverses murine cardiac hypertrophy. Li HL; Liu C; de Couto G; Ouzounian M; Sun M; Wang AB; Huang Y; He CW; Shi Y; Chen X; Nghiem MP; Liu Y; Chen M; Dawood F; Fukuoka M; Maekawa Y; Zhang L; Leask A; Ghosh AK; Kirshenbaum LA; Liu PP J Clin Invest; 2008 Mar; 118(3):879-93. PubMed ID: 18292803 [TBL] [Abstract][Full Text] [Related]
6. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Bowers EM; Yan G; Mukherjee C; Orry A; Wang L; Holbert MA; Crump NT; Hazzalin CA; Liszczak G; Yuan H; Larocca C; Saldanha SA; Abagyan R; Sun Y; Meyers DJ; Marmorstein R; Mahadevan LC; Alani RM; Cole PA Chem Biol; 2010 May; 17(5):471-82. PubMed ID: 20534345 [TBL] [Abstract][Full Text] [Related]
7. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy. Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703 [TBL] [Abstract][Full Text] [Related]
8. CBP/p300 inhibitor C646 prevents high glucose exposure induced neuroepithelial cell proliferation. Bai B; Zhang Q; Wan C; Li D; Zhang T; Li H Birth Defects Res; 2018 Aug; 110(14):1118-1128. PubMed ID: 30114346 [TBL] [Abstract][Full Text] [Related]
9. Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines. Wang YM; Gu ML; Meng FS; Jiao WR; Zhou XX; Yao HP; Ji F Int J Oncol; 2017 Dec; 51(6):1860-1868. PubMed ID: 29075795 [TBL] [Abstract][Full Text] [Related]
10. Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface. Wei J; Joshi S; Speransky S; Crowley C; Jayathilaka N; Lei X; Wu Y; Gai D; Jain S; Hoosien M; Gao Y; Chen L; Bishopric NH JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878124 [TBL] [Abstract][Full Text] [Related]
11. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. Morimoto T; Sunagawa Y; Kawamura T; Takaya T; Wada H; Nagasawa A; Komeda M; Fujita M; Shimatsu A; Kita T; Hasegawa K J Clin Invest; 2008 Mar; 118(3):868-78. PubMed ID: 18292809 [TBL] [Abstract][Full Text] [Related]
12. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Wei JQ; Shehadeh LA; Mitrani JM; Pessanha M; Slepak TI; Webster KA; Bishopric NH Circulation; 2008 Aug; 118(9):934-46. PubMed ID: 18697823 [TBL] [Abstract][Full Text] [Related]
13. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro. Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780 [TBL] [Abstract][Full Text] [Related]
14. Insights into intermolecular interactions, electrostatic properties and the stability of C646 in the binding pocket of p300 histone acetyltransferase enzyme: a combined molecular dynamics and charge density study. Sivanandam M; Saravanan K; Kumaradhas P J Biomol Struct Dyn; 2018 Sep; 36(12):3246-3264. PubMed ID: 28948877 [TBL] [Abstract][Full Text] [Related]
15. Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agents. Yang H; Pinello CE; Luo J; Li D; Wang Y; Zhao LY; Jahn SC; Saldanha SA; Chase P; Planck J; Geary KR; Ma H; Law BK; Roush WR; Hodder P; Liao D Mol Cancer Ther; 2013 May; 12(5):610-20. PubMed ID: 23625935 [TBL] [Abstract][Full Text] [Related]
16. Zyxin protects from hypertension-induced cardiac dysfunction. Al-Hasani J; Sens-Albert C; Ghosh S; Trogisch FA; Nahar T; Friede PAP; Reil JC; Hecker M Cell Mol Life Sci; 2022 Jan; 79(2):93. PubMed ID: 35075545 [TBL] [Abstract][Full Text] [Related]